Hairy cell leukemia in Hong Kong Chinese: a 12-year retrospective survey.
BACKGROUND
Hairy cell leukemia (HCL) is a unique chronic B cell lymphoproliferative disease (B-LPD), with distinct clinical and pathological features, and excellent treatment response to 2-chlorodeoxyadenosine (2-CDA) and pentostatin. There have been few reports of HCL from oriental countries.


METHODS
A retrospective survey of HCL in six major hematology units in Hong Kong over a 12-year period.


RESULTS
There were 18 cases of HCL identified. Most patients presented with fever, splenomegaly and monocytopenia. Lymphadenopathy was present in three patients, and open biopsy revealed tuberculosis infection in two cases. Seven cases received interferon and 12 cases received 2-CDA. Four patients died from bronchogenic carcinoma, cerebral vascular accident, fulminant hepatitis B virus reactivation and malignant melanoma. The remaining 14 patients are in clinical remission at a median of 6 years' follow-up; two are also surviving from second malignancies (thyroid papillary carcinoma and renal cell carcinoma).


CONCLUSIONS
Parallel to the low incidence of B-LPD in Chinese, the incidence of HCL (0.035/100000 population per year) is much lower than in Western series. Other clinical features such as male dominance, clinical presentation, response to 2-CDA treatment, and association with second malignancy are similar to Western reports. However, two common complications in the Chinese population are the fulminant reactivation of hepatitis B infection and disseminated tuberculosis infection.
Au
W Y
WY
Department of Medicine, Queen Mary Hospital, Hong Kong. auwing@hotmail.com
Kwong
Y L
YL
Ma
S K
SK
Mak
Y K
YK
Wong
K F
KF
Lei
K I
KI
Ng
M H
MH
Chan
J C
JC
Lin
S Y
SY
Lee
K K
KK
Liang
R
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000453:epidemiology / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies